FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1234933008: Product containing only aluminium hydroxide and magnesium hydroxide and oxetacaine in oral dose form (medicinal product form)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2022. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5084766016 Aluminum hydroxide and magnesium hydroxide and oxethazaine only product in oral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5084767013 Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5084768015 Product containing only aluminium hydroxide and magnesium hydroxide and oxetacaine in oral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5084766016 Aluminum hydroxide and magnesium hydroxide and oxethazaine only product in oral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5084767013 Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5084768015 Product containing only aluminium hydroxide and magnesium hydroxide and oxetacaine in oral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form Is a Aluminium hydroxide- and magnesium hydroxide- and oxetacaine-containing product in oral dose form true Inferred relationship Existential restriction modifier (core metadata concept)
Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form Has manufactured dose form Oral dose form true Inferred relationship Existential restriction modifier (core metadata concept)
Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form Plays role Laxative therapeutic role (role) false Inferred relationship Existential restriction modifier (core metadata concept)
Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Oxetacaine true Inferred relationship Existential restriction modifier (core metadata concept) 1
Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Magnesium hydroxide true Inferred relationship Existential restriction modifier (core metadata concept) 2
Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form Is a Product containing only aluminium hydroxide and magnesium hydroxide and oxetacaine (medicinal product) true Inferred relationship Existential restriction modifier (core metadata concept)
Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Aluminium hydroxide true Inferred relationship Existential restriction modifier (core metadata concept) 3
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely aluminium hydroxide 58.2 milligram/1 milliliter and magnesium hydroxide 19.6 milligram/1 milliliter and oxetacaine 2 milligram/1 milliliter conventional release oral suspension (clinical drug) Is a True Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form Inferred relationship Existential restriction modifier (core metadata concept)

This concept is not in any reference sets

Back to Start